Fledgling Bio-Matrix Scientific (BMSN) And Big Pharma Pfizer (PFE) Look To Unite Projects Biotech News Stock Review Fledgling Bio-Matrix Scientific (BMSN) And Big Pharma Pfizer (PFE) Look To Unite Projects Biotech News Stock Review.
Adam and I both believe that the next 30 days could be potentially explosive and provide BMSN shareholders with quite a ride, Adam forecasts a coming PR concerning negotiations with Pfizer (PFE).
About Biotech News Stock Review
Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing. Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts. If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.